Tumour DNA in the blood can predict lung cancer outcome
On Jan. 13, 2025, scientists from the Francis Crick Institute, UCL, UCLH and Personalis announced they have found…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | Materials | Women's Health
Microplastics in the Air May Be Leading to Lung and Colon Cancers
On Dec. 18, 2024, researchers from the UC San Francisco released a study showing that tires and degrading…
Biotechnology | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved AstraZeneca’s Imfinzi for limited-stage small cell lung cancer
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Oncology
Artificial intelligence improved lung cancer diagnosis
On Aug. 23, 2024, A team of researchers from the University of Cologne announced they had created a…
Global cancer deaths among men projected to increase by 93% by 2050
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
U.S. Environmental Protection Agency finalized ban on ongoing uses of asbestos to protect people from cancer
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
Biotechnology | Disease | Medicine | NIH | Ophthalmogy | Therapeutics
NIH study confirmed benefit of supplements for slowing age-related macular degeneration
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
Biotechnology | Diagnostics | Disease | Environmental | Genomics | Life Science News | NIH | Oncology
NIH study illuminated origins of lung cancer in never smokers
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
American Cancer Society reported largest one-year drop in cancer mortality from 1991-2017
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first adjuvant therapy for most common type of lung cancer
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Therapeutics
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Vaccine
Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
The CPRIT awarded academic research and prevention grants totaling $73.5 million
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
Biotechnology | Chemical | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
Genentech drug Alecensa (alectinib) was approved by FDA
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…
Southwestern lung cancer researcher Dr John Minna named Giant of Cancer Care
On Oct. 6, 2015, Cancer biologist Dr. John Minna, with the Harold C. Simmons Comprehensive Cancer Center at…
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
Genetic region linked to a five times higher lung cancer risk
On Sept. 2008, a narrow region on chromosome 15 contains genetic variations strongly associated with familial lung cancer,…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Oncology | Therapeutics
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
The Winship Cancer Institute received a $7.9 million, 5-year grant from the NCI to study cell signaling in lung cancer
In 2006, the Winship Cancer Institute received a $7.9 million P01 5-year grant from the Cancer Institute (NCI)…
UW Doctor performed SCCA’s first video-assisted thoracic surgery
In 2005, Dr. Michael Mulligan from the University of Washington performed Seattle Cancer Care Alliance’s (SCCA) first video-assisted…